UBS AM’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,320
| Closed | -$313K | – | 2596 |
|
|
2023
Q2 | $313K | Hold |
4,320
| – | – | ﹤0.01% | 2464 |
|
|
2023
Q1 | $313K | Buy |
+4,320
| New | +$313K | ﹤0.01% | 2464 |
|
|
2022
Q4 | – | Sell |
-3,261
| Closed | -$308K | – | 2573 |
|
|
2022
Q3 | $308K | Hold |
3,261
| – | – | ﹤0.01% | 2487 |
|
|
2022
Q2 | $635K | Hold |
3,261
| – | – | ﹤0.01% | 2199 |
|
|
2022
Q1 | $757K | Buy |
3,261
+331
| +11% | +$76.9K | ﹤0.01% | 2274 |
|
|
2021
Q4 | $1.15M | Buy |
2,930
+2
| +0.1% | +$788 | ﹤0.01% | 2137 |
|
|
2021
Q3 | $1.31M | Sell |
2,928
-516
| -15% | -$231K | ﹤0.01% | 2031 |
|
|
2021
Q2 | $1.34M | Buy |
3,444
+211
| +7% | +$82K | ﹤0.01% | 2041 |
|
|
2021
Q1 | $1.16M | Hold |
3,233
| – | – | ﹤0.01% | 2018 |
|
|
2020
Q4 | $1.59M | Buy |
3,233
+814
| +34% | +$399K | ﹤0.01% | 1781 |
|
|
2020
Q3 | $784K | Sell |
2,419
-188
| -7% | -$60.9K | ﹤0.01% | 1942 |
|
|
2020
Q2 | $950K | Buy |
2,607
+240
| +10% | +$87.4K | ﹤0.01% | 1837 |
|
|
2020
Q1 | $503K | Buy |
2,367
+567
| +32% | +$121K | ﹤0.01% | 1976 |
|
|
2019
Q4 | $741K | Sell |
1,800
-12,514
| -87% | -$5.15M | ﹤0.01% | 2071 |
|
|
2019
Q3 | $5.05M | Buy |
14,314
+3,603
| +34% | +$1.27M | ﹤0.01% | 1200 |
|
|
2019
Q2 | $5.38M | Buy |
10,711
+1,632
| +18% | +$820K | ﹤0.01% | 1172 |
|
|
2019
Q1 | $9.02M | Buy |
9,079
+36
| +0.4% | +$35.8K | 0.01% | 960 |
|
|
2018
Q4 | $7.85M | Buy |
9,043
+346
| +4% | +$301K | 0.01% | 939 |
|
|
2018
Q3 | $8.99M | Sell |
8,697
-609
| -7% | -$630K | 0.01% | 961 |
|
|
2018
Q2 | $8.55M | Buy |
9,306
+8,694
| +1,421% | +$7.99M | 0.01% | 986 |
|
|
2018
Q1 | $596K | Buy |
+612
| New | +$596K | ﹤0.01% | 1965 |
|
|
2017
Q1 | – | Sell |
-19,007
| Closed | -$6.75M | – | 2459 |
|
|
2016
Q4 | $6.75M | Sell |
19,007
-15,106
| -44% | -$5.36M | 0.01% | 938 |
|
|
2016
Q3 | $18.2M | Sell |
34,113
-11,994
| -26% | -$6.41M | 0.02% | 711 |
|
|
2016
Q2 | $25.9M | Sell |
46,107
-2,519
| -5% | -$1.42M | 0.03% | 568 |
|
|
2016
Q1 | $23.1M | Sell |
48,626
-791
| -2% | -$376K | 0.03% | 601 |
|
|
2015
Q4 | $32.6M | Buy |
49,417
+5,195
| +12% | +$3.43M | 0.04% | 490 |
|
|
2015
Q3 | $34.8M | Buy |
44,222
+19,442
| +78% | +$15.3M | 0.04% | 487 |
|
|
2015
Q2 | $32.7M | Buy |
24,780
+18,615
| +302% | +$24.6M | 0.03% | 550 |
|
|
2015
Q1 | $6.41M | Buy |
6,165
+3,873
| +169% | +$4.03M | 0.01% | 1000 |
|
|
2014
Q4 | $1.53M | Buy |
+2,292
| New | +$1.53M | ﹤0.01% | 1437 |
|